Heart failure patients with reduced or mildly reduced ejection fraction: baseline characteristics of the low-dose digoxin outcome DECISION trial
DECISION enrolled a contemporary and well-treated population of patients with HFrEF and HFmrEF and will provide important evidence regarding the efficacy and safety of low-dose digoxin on outcome in patients with reduced or mildly reduced LVEF.
Authors
- Geert H.D. Voordes (ORCID: https://orcid.org/0000-0001-8403-0562)
- A. Mosterd
- Marlene A. T. Vijver (ORCID: https://orcid.org/0000-0003-2587-8402)
- Astrid Schut (ORCID: https://orcid.org/0000-0001-9397-7109)
- Kevin Damman (ORCID: https://orcid.org/0000-0003-0190-2228)
- A. Vos
- M. Rienstra
- Jeroen Schaap
- Dirk J. Lok
- JG Tijssen
- E. E. van der Wall
- Iris C D Westendorp
- Marcel L. Bouvy
- Dirk J van Veldhuisen
- Peter van der Meer
- Antoinette D van Asselt
- Adriaan A Voors
- A Marco Alings
- Ester L Maas-Soer
- Harry J Crijns
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
- Leiden University Medical Center (NL)
- Maastricht University (NL)
- Red Cross Hospital (GR)
- Amphia Ziekenhuis (NL)
- Pharmo Institute (NL)
- Amsterdam University Medical Centers (NL)
- Deventer Ziekenhuis (NL)
- Meander Medisch Centrum (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- European Journal of Heart Failure
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1093/ejhf/xuag073
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00